申请人:Matsuoka Masato
公开号:US20100048537A1
公开(公告)日:2010-02-25
The present invention relates to a compound represented by formula [1] or a pharmaceutically acceptable salt thereof:
In formula [1], one of X and Y is CH and the other is oxygen or sulfur; R is hydrogen, etc.; Z is hydrogen, etc.; Ar is phenyl, etc.; and n is 1 or 2 and or m is 1 or 2, excluding compounds where n is 2 and m is 2 simultaneously. Also provided is a pharmaceutical composition comprising a compound of formula [1] or a pharmaceutically acceptable salt thereof as an active ingredient. The composition is usable as an agent for the prevention or treatment of depression, panic disorder, anxiety, obsessive-compulsive disorder, chronic pain, fibromyalgia, obesity, stress urinary incontinence, and overactive bladder.
本发明涉及一种由公式[1]表示的化合物或其药学上可接受的盐:
在公式[1]中,X和Y中的一个是CH,另一个是氧或硫;R是氢等;Z是氢等;Ar是苯等;n为1或2,m为1或2,不包括n为2且m为2的化合物。还提供了一种药物组合物,其包括公式[1]的化合物或其药学上可接受的盐作为活性成分。该组合物可作为预防或治疗抑郁症、惊恐障碍、焦虑症、强迫症、慢性疼痛、纤维肌痛、肥胖症、压力性尿失禁和过度活动膀胱的药物。